Welcome To Guidepoint Qsight!

The medical aesthetics market is shifting from a growth story built on patient volume to one built on retention, spend per patient, and the treatments patients are chasing next.

U.S. Medical Aesthetics: A Data-Driven Perspective unpacks what’s driving 2026 growth, how skin rejuvenation outpaces the category, neurotoxin brands fragmenting as challengers gain share, and GLP-1 & HRT emerging as new anchors in the patient journey.

Guidepoint Qsight combines real world data with deep industry expertise to help leaders understand these shifts and act decisively.

Access "U.S. Medical Aesthetics: A Data-Driven Perspective"

Comments
This field is for validation purposes and should be left unchanged.
Name
First Last
Email
Company
Consent*
We’d like to keep in touch. Check this box to authorize Guidepoint Qsight to contact you by email.*
CAPTCHA